Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Pozniak, Anton"'
Autor:
Orkin C; Queen Mary University of London, London, UK., Antinori A; National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy., Rockstroh JK; University Hospital Bonn, Bonn, Germany., Moreno-Guillén S; Hospital Ramón y Cajal, Madrid, Spain., Martorell CT; The Research Institute, Springfield, Massachusetts, USA., Molina JM; University of Paris Cité, Department of Infectious Diseases, Hôpital Saint-Louis and Lariboisière, Paris, France., Lazzarin A; San Raffaele Hospital Milan, Milan, Italy., Maggiolo F; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Yazdanpanah Y; AP-HP Hôpital Bichat, Paris, France., Andreatta K; Gilead Sciences, Inc., Foster City, California, USA., Huang H; Gilead Sciences, Inc., Foster City, California, USA., Hindman JT; Gilead Sciences, Inc., Foster City, California, USA., Martin H; Gilead Sciences, Inc., Foster City, California, USA., Pozniak A; Chelsea and Westminster Hospital, London, UK.
Publikováno v:
AIDS (London, England) [AIDS] 2024 Jun 01; Vol. 38 (7), pp. 983-991. Date of Electronic Publication: 2024 Feb 21.
Autor:
Pilkington V; Faculty of Medicine, Imperial College London.; MetaVirology LTD London.; Oxford University Clinical Academic Graduate School, Oxford., Hughes SL; MetaVirology LTD London., Pepperrell T; Faculty of Medicine, Imperial College London.; MetaVirology LTD London., McCann K; MetaVirology LTD London., Gotham D; Faculty of Medicine, Imperial College London., Pozniak AL; Chelsea & Westminster Hospital NHS Foundation Trust, London., Hill A; Faculty of Medicine, Imperial College London.; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
Publikováno v:
AIDS (London, England) [AIDS] 2020 Dec 01; Vol. 34 (15), pp. 2259-2268.
Autor:
Gupta SK; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Post FA; King's College Hospital NHS Foundation Trust, London, UK., Arribas JR; Instituto de Investigación Hospital Universitario La Paz, Hospital Universitario La Paz, Madrid, Spain., Eron JJ Jr; Division of Infectious Diseases, Department of Medicine, UNC School of Medicine., Wohl DA; Division of Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Clarke AE; Sexual Health and Clinical Trials, Royal Sussex County Hospital, Brighton, UK., Sax PE; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Stellbrink HJ; Infectious Disease Medical Center, Hamburg., Esser S; Universitatsklinikum, Essen, Germany., Pozniak AL; Chelsea and Westminster Hospital and St Stephens AIDS Trust, London, UK., Podzamczer D; Infectious Diseases Service, Hospital Universitario de Bellvitge, Barcelona, Spain., Waters L; Mortimer Market Centre., Orkin C; Barts Health NHS Trust, Ambrose King Centre, Royal London Hospital, London, UK., Rockstroh JK; University Hospital Bonn, Bonn, Germany., Mudrikova T; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Negredo E; Universitat de Vic-Universitat Central de Catalunya, Barcelona, Spain., Elion RA; Department of Clinical Investigations, Whitman-Walker Health, Washington, District of Columbia., Guo S; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., Zhong L; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., Carter C; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., Martin H; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., Brainard D; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., SenGupta D; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA., Das M; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v:
AIDS (London, England) [AIDS] 2019 Jul 15; Vol. 33 (9), pp. 1455-1465.
Autor:
Gotham D; aFaculty of Medicine, Imperial College London bDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool cChelsea and Westminster Hospital NHS Foundation Trust, St Stephens AIDS Trust, London, UK., Hill A, Pozniak AL
Publikováno v:
Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2017 Jul; Vol. 12 (4), pp. 324-333.
Autor:
Pozniak A; Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom; †Department of Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ‡Therapeutic Concepts, Houston, TX; §Department of Medicine, Indiana University School of Medicine, Indianapolis, IN; ‖King's College Hospital NHS Foundation Trust, London, United Kingdom; ¶Holdsworth House Medical Practice, Sydney, Australia; #HIV-NAT, Thai Red Cross AIDS Research Centre and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; **Gordon Crofoot Research, Houston, TX; ††Be Well Medical Center, Berkley, MI; ‡‡Department of Medicine, National Jewish Health, Denver, CO; §§Midway Research Center, Ft. Pierce, FL; ‖‖Department of Medicine, Khon Kaen University, Thailand; and ¶¶Gilead Sciences, Foster City, CA., Arribas JR, Gathe J, Gupta SK, Post FA, Bloch M, Avihingsanon A, Crofoot G, Benson P, Lichtenstein K, Ramgopal M, Chetchotisakd P, Custodio JM, Abram ME, Wei X, Cheng A, McCallister S, SenGupta D, Fordyce MW
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2016 Apr 15; Vol. 71 (5), pp. 530-7.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sax, Paul E, Wohl, David, Yin, Michael T., Post, Frank, Dejesus, Edwin, Saag, Michael, Pozniak, Anton, Thompson, Melanie, Podzamczer, Daniel, Molina, Jean Michel, Oka, Shinichi, Koenig, Ellen, Trottier, Benoit, Andrade Villanueva, Jaime, Crofoot, Gordon, Custodio, Joseph M., Plummer, Andrew, Zhong, Lijie, Cao, Huyen, Martin, Hal, Callebaut, Christian, Cheng, Andrew K., Fordyce, Marshall W., Mccallister, Scott, for the GS US 292 0104/0111 Study Team [. . ., VIALE, PIERLUIGI
Publikováno v:
Lancet (London, England). 385(9987)
Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir concentrations. Tenofovir ala
Autor:
Raffi, François, Gaultier, Aurélie, Pozniak, Anton, Molina, Jean-Michel, Jessen, Heiko, Antinori, Andrea, Soria, Albane, Cavellec, Morane, Thuaut, Aurélie Le, Ningre, Maelle, Wit, Stéphane de, Le Thuaut, Aurélie, de Wit, Stéphane
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Jun2020, Vol. 75 Issue 6, p1618-1622, 5p